FASN and cancer: In cancer, fatty acids, whatever the levels of circulating triglycerides, are preferentially obtained by the activation of FASN gene products in order to engage a de novo synthesis of palmitate as opposed to what normally happens in healthy cells of well-nourished adult individuals, which tend to rely on fatty acids obtained from the diet (Menendez and Lupu, 2007; Lo et al., 2017).